Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
24 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-announces-clinical-trial-agreement-to-evaluate-rezpegaldesleukin-in-patients-with-new-onset-type-1-diabetes-mellitus-302383052.html
10 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-receives-fast-track-designation-for-rezpegaldesleukin-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-302371995.html
02 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ampersand-capital-partners-completes-acquisition-of-nektar-therapeutics-peg-reagent-manufacturing-business-launching-newly-branded-gannet-biochem-302319679.html
18 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-presents-first-preclinical-data-from-novel-csf-1-program-nktr-422-at-2024-american-college-of-rheumatology-acr-convergence-302307672.html
07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-and-collaborators-present-late-breaking-results-from-phase-2-study-of-nktr-255-for-the-treatment-of-radiation-induced-lymphopenia-in-locally-advanced-non-small-cell-lung-cancer-patients-at-society-for-immunotherapy-of-cance-302298158.html
05 Nov 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/beleaguered-nektar-pads-wallet-90m-manufacturing-plant-sale-ampersand
Excipients
Inspections and registrations
ABOUT THIS PAGE
Nektar Therapeutics is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of Macrogol bulk with DMF offered by Nektar Therapeutics
Find a price of NKTR-255 DRUG SUBSTANCE bulk with DMF offered by Nektar Therapeutics
Find a price of NKTR-255 DRUG PRODUCT bulk with DMF offered by Nektar Therapeutics
Find a price of Amikacin bulk offered by Nektar Therapeutics
Find a price of Lysine bulk offered by Nektar Therapeutics
Find a price of Macrogol bulk offered by Nektar Therapeutics
Find a price of PEG2MAL40K bulk offered by Nektar Therapeutics